High Risk Myelodysplastic Neoplasia clinical trials

Explore recruiting high risk myelodysplastic neoplasia clinical trials.

Recruiting high risk myelodysplastic neoplasia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Myelodysplastic Neoplasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem cell transplantation, a Phase 2, Single-arm, Open-Label Study (MAGROLIC)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation (alloSCT) In Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Neoplasia (HR-MDS) with IDH1 Mutation (PIVOT)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

High Risk Myelodysplastic Neoplasia trials by city

High Risk Myelodysplastic Neoplasia in Toronto High Risk Myelodysplastic Neoplasia in Vancouver High Risk Myelodysplastic Neoplasia in Montreal High Risk Myelodysplastic Neoplasia in Calgary High Risk Myelodysplastic Neoplasia in Edmonton High Risk Myelodysplastic Neoplasia in Ottawa High Risk Myelodysplastic Neoplasia in Winnipeg High Risk Myelodysplastic Neoplasia in Quebec City High Risk Myelodysplastic Neoplasia in Hamilton High Risk Myelodysplastic Neoplasia in Kitchener High Risk Myelodysplastic Neoplasia in London High Risk Myelodysplastic Neoplasia in Halifax High Risk Myelodysplastic Neoplasia in New York High Risk Myelodysplastic Neoplasia in Los Angeles High Risk Myelodysplastic Neoplasia in Chicago High Risk Myelodysplastic Neoplasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease